cgp 12177 has been researched along with Alloxan Diabetes in 3 studies
CGP 12177 : A benzimidazole that is benzimidazol-2-one substituted at position 4 by a 3-(tert-butylamino)-2-hydroxypropoxy group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Thackeray, JT | 1 |
Parsa-Nezhad, M | 1 |
Kenk, M | 1 |
Thorn, SL | 1 |
Kolajova, M | 1 |
Beanlands, RS | 1 |
DaSilva, JN | 1 |
Komabayashi, T | 1 |
Ikeda, T | 1 |
Suda, K | 1 |
Izawa, T | 1 |
Kashiwagi, A | 1 |
Nishio, Y | 1 |
Saeki, Y | 1 |
Kida, Y | 1 |
Kodama, M | 1 |
Shigeta, Y | 1 |
3 other studies available for cgp 12177 and Alloxan Diabetes
Article | Year |
---|---|
Reduced CGP12177 binding to cardiac β-adrenoceptors in hyperglycemic high-fat-diet-fed, streptozotocin-induced diabetic rats.
Topics: Adrenergic beta-Antagonists; Animals; Biomarkers; Blotting, Western; Diabetes Mellitus, Experimental | 2011 |
Beta-adrenergic receptors and adenylate cyclase activity in the parotid acinar cells from acute streptozotocin-induced diabetic rats.
Topics: Adenylyl Cyclases; Amylases; Animals; Diabetes Mellitus, Experimental; Enzyme Activation; Isoprotere | 2000 |
Plasma membrane-specific deficiency in cardiac beta-adrenergic receptor in streptozocin-diabetic rats.
Topics: Adrenergic beta-Antagonists; Animals; Cell Membrane; Cells, Cultured; Diabetes Mellitus, Experimenta | 1989 |